PAK4 and rhabdomyosarcoma: In rhabdomyosarcoma (RMS), analysis of transcriptomic data from RMS tumors treated with and without a PAK4 inhibitor illustrated that GTPase/Ras signaling, as well as Notch and Hedgehog signaling, were downregulated when PAK4 was inhibited [11].